Acquisition by Karin Walker of 54000 shares of Prothena Plc subject to Rule 16b-3

PRTA Stock  USD 14.53  0.75  5.44%   
About 57% of all Prothena Plc's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Prothena plc suggests that some traders are interested. The current market sentiment, together with Prothena Plc's historical and current headlines, can help investors time the market. In addition, many technical investors use Prothena plc stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Prothena Corp Public Ltd officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Prothena insider trading alert for grant of stock option right to buy by Karin Walker, Chief Accounting Officer, on 29th of February 2024. This event was filed by Prothena Corp Public Ltd with SEC on 2024-02-29. Statement of changes in beneficial ownership - SEC Form 4. Karin Walker currently serves as chief accounting officer and controller of Prothena Plc

Cash Flow Correlation

Prothena Plc's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Prothena Plc's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Prothena Plc Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Prothena Plc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Prothena Plc Fundamental Analysis

We analyze Prothena Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Prothena Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Prothena Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

Prothena Plc is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Prothena plc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Prothena Plc stock to make a market-neutral strategy. Peer analysis of Prothena Plc could also be used in its relative valuation, which is a method of valuing Prothena Plc by comparing valuation metrics with similar companies.

Peers

Prothena Plc Related Equities

STOKStoke Therapeutics   12.07   
0%
100.0%
VTYXVentyx Biosciences   6.12   
0%
50.0%
PCVXVaxcyte   2.95   
0%
24.0%
CGEMCullinan Oncology   1.25   
0%
10.0%
PLRXPliant Therapeutics   0.48   
0%
3.0%
KNSAKiniksa Pharmaceuticals   0.19   
1.0%
0%
MISTMilestone Pharmaceuticals   0.54   
4.0%
0%
NUVLNuvalent   0.56   
4.0%
0%
VRDNViridian Therapeutics   0.65   
5.0%
0%
MDGLMadrigal Pharmaceuticals   0.90   
7.0%
0%
IMCRImmunocore Holdings   1.46   
12.0%
0%
ACLXArcellx   3.16   
26.0%
0%
ONCYOncolytics Biotech   3.30   
27.0%
0%
SCPHScpharmaceuticals   3.89   
32.0%
0%
ETNB89bio   4.93   
40.0%
0%
MCRBSeres Therapeutics   6.82   
56.0%
0%

Complementary Tools for Prothena Stock analysis

When running Prothena Plc's price analysis, check to measure Prothena Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prothena Plc is operating at the current time. Most of Prothena Plc's value examination focuses on studying past and present price action to predict the probability of Prothena Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prothena Plc's price. Additionally, you may evaluate how the addition of Prothena Plc to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
CEOs Directory
Screen CEOs from public companies around the world